Please login to the form below

Not currently logged in
Email:
Password:

European biotech

This page shows the latest European biotech news and features for those working in and with pharma, biotech and healthcare.

Investments show UK biotech still booming despite Brexit

Investments show UK biotech still booming despite Brexit

UK raised a quarter of all European biotech funds. New figures show the UK life science sector is still in good health, with a strong start to fundraising in early 2019, ... This reflects a continuing shift away from biotech IPOs on European markets,

Latest news

  • Novartis and Syncona back new Swiss biotech Anaveon Novartis and Syncona back new Swiss biotech Anaveon

    Based in Basel, the centre of Switzerland's pharma and biotech cluster, the company has just raised CHF 35m ($34.9m) in a series A financing round.

  • Ex-Pharmacyclics CEO invests $25m in Summit Ex-Pharmacyclics CEO invests $25m in Summit

    After Duchenne drug failure, UK biotech looks to new anti-infective. US biotech billionaire Bob Duggan is to invest $25m into antibiotics developer Summit Therapeutics, taking a near-49% stake in ... Bob Duggan. Duggan was chief executive and president

  • Encouraging data for GenSight’s blinding retinal disease gene therapy Encouraging data for GenSight’s blinding retinal disease gene therapy

    Luxturna, was the first ever gene therapy to be approved for any form of genetic blindness in the US, and now it’s edging closer to that all important European approval. ... UK biotech startup Nightstar is also making waves in this space, bagging a fast

  • New leader at Medivir after setbacks New leader at Medivir after setbacks

    Christine Lind departs Swedish biotech. Shares in Swedish biotech Medivir were sliding this morning on the sudden departure of chief executive Christine Lind, to be replaced by board member Uli Hacksell. ... Hacksell – who is described in a statement

  • Orchard plans IPO as gene therapy pipeline advances Orchard plans IPO as gene therapy pipeline advances

    UK biotech seeks funds for expanded rare disease portfolio. UK gene therapy specialist Orchard Therapeutics has filed registration documents for an initial public offering, just weeks after its latest $150m private ... Add in capital projects such as a

More from news
Approximately 11 fully matching, plus 31 partially matching documents found.

Latest Intelligence

  • European venture funding for the life science sector European venture funding for the life science sector

    Capital markets infrastructure is a barrier. European biotech companies continue to find it hard to raise public money in Europe. ... Pockets of success on Euronext mask the fact that leading European venture groups primarily look to the Nasdaq, at least

  • European sites European sites

    very large European life science industry offers a fertile ground for investments, collaboration and acquisitions. ... Key findings. In total there are roughly 11, 000 life science companies (biotech, pharma, medtech) across 14 European countries and in

  • Pharma deals in March 2015 Pharma deals in March 2015

    One of Bavarian Nordic's sites is in Martinsried, the biotech cluster near Munich. ... The Morphosys story highlights the uncertainty of funding for European biotech companies.

  • Pharma deals during December 2012 Pharma deals during December 2012

    Another deal involving European biotech companies is the acquisition of the Austrian company Intercell by Vivalis based in France for an all share deal valued at $174m. ... Both companies are loss making. It is billed as “a merger of equals”, with

  • Interview with Andrea Rappagliosi, EuropaBio Interview with Andrea Rappagliosi, EuropaBio

    The current financial crisis exacerbates the task. I think that in the wider context of the pharmaceutical industry, the European biotech industry can definitely play a role in boosting investment in ... From a biotech perspective, the proposed single

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics